Method for treating and preventing secondary hyperparathyroidism
US5602116A · kind A · utility
53Cited by
8References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 3, 1995 |
| Grant date | Feb 11, 1997 |
| Priority date | — |
| Expiry date | Apr 3, 2015 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for preventing loss of bone mass or bone mineral content in a human being suffering from secondary hyperparathyroidism by administering a sufficient amount of 1.alpha.-OH vitamin D.sub.2, 1.alpha.,24(S)-(OH).sub.2 vitamin D.sub.2, 1.alpha.-OH vitamin D.sub.4 or 1.alpha.,24(R)-(OH).sub.2 vitamin D.sub.4.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.